Results 291 to 300 of about 83,758 (359)

Recurrent hemoptysis after laryngectomy-acquired hemophilia induced by laryngeal cancer surgery and chemoradiotherapy: A case report. [PDF]

World J Clin Cases
Zhao PW, Hu YS, Jiang Z, Ainiwaer M, Liu J, Chen F.   +5 more
europepmc   +1 more source

Elevated circulation postsynaptic density protein 95 as a potential biomarker for predicting the diagnosis and prognosis of acute cerebral infarction. [PDF]

BMC Neurol
Dong Y, He Z, Lin H, Ye Z, Qin C, Li P.
europepmc   +1 more source

Dual guided heparin monitoring with anti-Xa and APTT during micro-axial flow pump support for cardiogenic shock

Charlotte Van Edom, Francesca Fiorelli, Tim Balthazar, Marc Jacquemin, Bart Meyns, María Monteagudo‐Vela, Susanna Price, Alexander J. Rosenberg, Hatem Soliman-Aboumarie, Guido Tavazzi, Alexander Tindale, Lorenz Van der Linden, Thomas Vanassche, Vasileios Panoulas, Christophe Vandenbriele   +14 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors

Seminars in Thrombosis and Hemostasis, 2019
The activated partial thromboplastin time (APTT) assay is a very common coagulation test, used for several reasons. The test is conventionally used for assessing the contact factor (intrinsic) pathway of blood coagulation, and thus for screening ...
G W Kershaw, Giuseppe Lippi, Emmanuel J Favaloro   +2 more
exaly   +2 more sources

Effect of an activated charcoal product (DOAC Stop™) intended for extracting DOACs on various other APTT-prolonging anticoagulants

Clinical Chemistry and Laboratory Medicine, 2019
Background The aim of the study was to investigate the specificity of an activated charcoal-based product (DOAC Stop™) initially intended for the specific extraction of direct oral anticoagulants (DOACs) from test plasmas on a range of other ...
Thomas Exner
exaly   +2 more sources

Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate

Thrombosis and Haemostasis, 2013
François Mullier, Paul Hjemdahl, Jonathan Douxfils   +2 more
exaly   +2 more sources

APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica‐based reagent

Journal of Thrombosis and Haemostasis, 2012
O. Kumano, M. Ieko, S. Naito, M. Yoshida, N. Takahashi   +4 more
exaly   +2 more sources

The responsiveness of different APTT reagents to mild factor VIII, IX and XI deficiencies

International Journal of Laboratory Hematology, 2011
A. Bowyer, S. Kitchen, M. Makris
exaly   +2 more sources